Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Henneman Insider Profile
4 Followers
John Henneman, CAO at Lumos Pharma, holds 9.31K shares in Anika Therapeutics (Ticker: ANIK), holds 60.46K shares in SeaSpine Holdings (Ticker: SPNE), holds 5.00K shares in Aprea Therapeutics (Ticker: APRE).
Profitable Transactions
10 out of 17 Profitable Transactions
Average Return
+0.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Henneman holds in companies
Most Profitable Insider Trade
The most profitable trade made by John Henneman
John Henneman's Trading History
Lumos Pharma
Oct 02, 2018
CAO
Uninformative Sell
5.66K
$825.23K
R1 RCM
Aug 17, 2016
Director
Informative Buy
90.02K
―
Aprea Therapeutics
Oct 07, 2019
Director
Informative Buy
75.00K
$132.25K
Anika Therapeutics
Sep 08, 2020
Director
Uninformative Buy
―
$356.29K
SeaSpine Holdings
Aug 05, 2020
Director
Uninformative Sell
150.00K
$858.50K
Integra Lifesciences
Aug 26, 2014
CorpVP, CAO
Informative Sell
1.00M
$1.90M
List of latest transactions for each holding click on a transaction to see John Henneman's performance on stock
You May Also Like
John Henneman insider profile FAQ
What is the percentage of profitable transactions made by John Henneman?
The percentage of profitable transactions made by John Henneman is 59%.
What is the average return per transaction made by John Henneman?
The average return per transaction made by John Henneman is 0.80%.
What stocks does John Henneman hold?
John Henneman holds: LUMO, RCM, APRE, ANIK, SPNE, IART stocks.
What was John Henneman’s latest transaction?
John Henneman latest transaction was an Uninformative Buy of ―.
What was John Henneman's most profitable transaction?
John Henneman’s most profitable transaction was an Informative Buy of RCM stock on August 17, 2016. The return on the trade was 81.60%.
What is John Henneman's role in Lumos Pharma?
John Henneman's role in Lumos Pharma is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.